financetom
Business
financetom
/
Business
/
Rexel Rejects Takeover Bid from QXO, Citing Undervaluation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rexel Rejects Takeover Bid from QXO, Citing Undervaluation
Sep 16, 2024 2:59 AM

05:29 AM EDT, 09/16/2024 (MT Newswires) -- Rexel said Sunday it rejected a takeover bid from QXO (QXO) after determining that it significantly undervalued the company.

Rexel refused the offer that was at an indicative price of 28 euros ($31.16) to 28.40 euros per share, saying the bid "does not reflect its value creation potential through its Power Up 25 strategic plan."

QXO did not immediately respond to MT Newswires' request for comment.

Price: 15.30, Change: +0.60, Percent Change: +4.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
InMode Urged by Investor DOMA Perpetual Capital Management to Buy Back Shares in Tender
InMode Urged by Investor DOMA Perpetual Capital Management to Buy Back Shares in Tender
Jul 25, 2024
11:38 AM EDT, 07/25/2024 (MT Newswires) -- InMode ( INMD ) faced a call from major shareholder DOMA Perpetual Capital Management to buy back 40% of the medical-device maker's stock in a tender offer. In the letter Wednesday to the InMode ( INMD ) board, DOMA expressed concerns over the capital allocation strategy and declining stock price. InMode's ( INMD...
ScPharmaceuticals New Drug Application Seeking to Expand Furoscix Indication Accepted for Filing by FDA
ScPharmaceuticals New Drug Application Seeking to Expand Furoscix Indication Accepted for Filing by FDA
Jul 25, 2024
11:32 AM EDT, 07/25/2024 (MT Newswires) -- ScPharmaceuticals ( SCPH ) said Thursday that the US Food and Drug Administration has accepted for filing its supplemental new drug application to expand the Furoscix indication to include edema treatment due to fluid overload in patients with chronic kidney disease. The FDA has set March 6, 2025, as a prescription drug user...
Update: Imperial Metals Up 1.9% as Q2 Copper and Gold Production Rises QoQ
Update: Imperial Metals Up 1.9% as Q2 Copper and Gold Production Rises QoQ
Jul 25, 2024
11:37 AM EDT, 07/25/2024 (MT Newswires) -- Imperial Metals ( IPMLF ) on Wednesday said second-quarter copper and gold production from its Mount Polley and Red Chris mines in British Columbia rose over the prior quarter. The company produced 15.5 million pounds of copper, up 26% from the first quarter and 13,768 ounces of gold, up 7%. The Mount Polley...
Stellantis triggers government scrutiny with Comau stake sale
Stellantis triggers government scrutiny with Comau stake sale
Jul 25, 2024
* Government could use golden powers to rein in deal * Sale will allow Stellantis ( STLA ) to focus on core Europe ops * Comau executive chair, CEO, will retain their jobs (Adds government response in paragraphs 1&4) By Giulio Piovaccari and Giuseppe Fonte MILAN, July 25 (Reuters) - Carmaker Stellantis has agreed to sell a majority stake in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved